Oxygen Transport to Tissue X pp 403-410 | Cite as
Brain Protection Against Oxygen Deficiency by Nizofenone
Chapter
First Online:
- 1 Citations
- 3 Mentions
- 190 Downloads
Abstract
Oxygen deprivation is one of the most damaging conditions affecting the brain. When the oxygen supply to the brain is deficient, oxidative energy metabolism ceases and all related metabolic activities are drastically changed, resulting in disorder of cerebral function and tissue deterioration. Much effort has been devoted to finding suitable agents which would enable the brain to withstand oxygen deficiency (Hossmann, 1982).
Keywords
Cerebral Ischemia Middle Cerebral Artery Occlusion Oxygen Deficiency Transient Cerebral Ischemia Cerebral Energy Metabolism
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Preview
Unable to display preview. Download preview PDF.
References
- Abramson N.S. and Brain Resuscitation Clinical Trial I Study Group, 1986, Randomized clinical study of thiopental loading in comatose survivors of cardiac arrest, New Eng. J. Med., 314: 397.Google Scholar
- Bazan N.G., 1970, Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain, Biochim. Biophys. Acta, 218: 1.CrossRefGoogle Scholar
- Chan P.H. and Fishman R.A., 1980, Transient formation of superoxide radicals in polyunsaturated fatty acid-induced brain swelling, J, Neurochem., 35: 1004.CrossRefGoogle Scholar
- Gryglewski R.J., Nowak S., Kostka-Trabka E., Kusmiderski J., Dembinska-Kiec A., Bieron K., Basista M. and Blaszczyk B., 1983, Treatment of ischemic stroke with prostacyclin, Stroke, 14: 197.CrossRefGoogle Scholar
- Hossmann K.A., 1982, Treatment of experimental cerebral ischemia, J. Cereb. Blood Flow Metabol., 3: 275.CrossRefGoogle Scholar
- Izumi N. and Yasuda H., 1983, A convenient cerebral ischemia model using mice, J. Cereb, Blood Flow Metabol., 3 (Suppl. 1): 391.Google Scholar
- Lowry O.H. and Passonneau J.V., 1972, “A flexible system of enzymatic analysis”, Academic Press, New York.Google Scholar
- Michenfelder J.D., Milde J.H. and Sundt T.M.Jr., 1976, Cerebral protection by barbiturate anesthesia, Arch. Neurol., 33: 345.CrossRefGoogle Scholar
- Nakanishi M., Yasuda H. and Tsumagari T., 1973, Protective effect of anti-anxiety drugs against hypoxia, Life Sci., 13: 467.CrossRefGoogle Scholar
- Nemoto E.M., Shiu G.K., Nemmer J. and Bleyaert A.L., 1982, Attenuation of brain free fatty acid liberation during global ischemia: a model for screening potential therapies for efficacy?, J. Cereb. Blood Flow Metab., 2: 475.CrossRefGoogle Scholar
- Ochiai C., Asano T., Tamura A., Sano K., Fukuda T. and Nakamura T., 1981, An experimental study on the mechanism of the protective action of pentobarbital and Y-9179 against cerebral ischemia, Neurol. Med. Chir. (Tokyo), 21: 303.CrossRefGoogle Scholar
- Ochiai C., Asano T., Takakura K., Fukuda T., Horizoe H. and Morimoto Y., 1982, Mechanisms of cerebral protection by pentobarbital and nizofenone correlated with the course of local cerebral blood flow changes, Stroke, 13: 788.CrossRefGoogle Scholar
- Ohta T., Kikuchi H., Hashi K. and Kudo Y., 1986, Nizofenone administration in the acute stage following subarachnoid hemorrhage. Results of a multi-center controlled double-blind clinical study, J. Neurosurg., 64: 420.CrossRefGoogle Scholar
- Saito I., Asano T., Ochiai C., Takakura K., Tamura A. and Sano K., 1983, A double-blind clinical evaluation of the effect of nizofenone (Y-9179) on delayed ischemic neurological deficits following aneurysmal rupture, Neurol, Res., 5: 29.Google Scholar
- Siesjo B.K., 1981, Cell damage in the brain: a speculative synthesis, J. Cereb. Blood Flow Metab., 1: 155.CrossRefGoogle Scholar
- Smith A.L., 1977, Barbiturate protection in cerebral hypoxia, Anesthesiology, 47: 285.CrossRefGoogle Scholar
- Tamura A., Asano T., Sano K., Tsumagari T. and Nakajima A., 1979, Protection from cerebral ischemia by a new imidazole derivative (Y-9179) and pentobarbital: A comparative study in chronic middle cerebral artery occlusion in cats, Stroke, 10: 126.CrossRefGoogle Scholar
- Yasuda H., Shuto S., Tsumagari T. and Nakajima A., 1978, Protective effect of a novel imidazole derivative against cerebral anoxia, Arch. Int. Pharmacodyn. Ther., 233: 136.PubMedGoogle Scholar
- Yasuda H., Nakanishi M., Tsumagari T., Nakajima A. and Nakanishi M., 1979, The mechanism of action of a novel cerebral protective drug against anoxia. I. The effect on cerebral energy demand, Arch. Int. Pharmacodyn. Ther., 242: 77.PubMedGoogle Scholar
- Yasuda H., Shimada O., Nakajima A. and Asano T., 1981, Cerebral protective effect and radical scavenging action, J. Neurochem., 37: 934.CrossRefGoogle Scholar
- Yasuda H., Nakanishi M. and Izumi N., 1983, Cerebral protection by pentetrazol against hypoxia, in: “Current Problems in Epilepsy”, Baldy-Moulinier M., Ingvar D.H. and Meldrum B.S. ed., John Libbey, London, pp. 292–296.Google Scholar
- Yasuda H., Ochi H. and Tsumagari T., 1984, Stimulation of prostacyclin synthesis by nizofenone, Biochem. Pharmacol., 33: 2707.CrossRefGoogle Scholar
- Yasuda H., Kishiro K., Izumi N. and Nakanishi M., 1985, Biphasic liberation of arachidonic and stearic acids during cerebral ischemia, J. Neurochem., 45: 168.CrossRefGoogle Scholar
- Yoshida S., Inoh S., Asano T., Sano K., Kubota M., Shimazaki H. and Ueta N., 1980, Effect of transient ischemia on free fatty acids and phospholipids in the gerbil brain: lipid peroxidation as a possible cause of postischemic injury, J. Neurosurg., 53: 323.CrossRefGoogle Scholar
- Yoshida S., Inoh S., Asano T., Sano K., Kubota M., Shimazaki H., Ueta N., Yasuda H. and Shimada O., 1980, Brain free fatty acids in transient cerebral ischemia and the effect of metabolic depressants, Brain Nerve, 32: 931.PubMedGoogle Scholar
Copyright information
© Plenum Press, New York 1988